Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa

被引:134
作者
Nachega, JB
Stein, DM
Lehman, DA
Hlatshwayo, D
Mothopeng, R
Chaisson, RE
Karstaedt, AS
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA
[2] Univ Witwatersrand, Dept Med, Chris Hani Baragwanath Hosp, Adult HIV Outpatient Clin, ZA-2001 Johannesburg, South Africa
[3] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA
关键词
D O I
10.1089/aid.2004.20.1053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little is known about achievable levels of antiretroviral treatment ( ART) adherence in resource-limited settings. We conducted a cross-sectional study of adherence among patients at Chris Hani Baragwanath Hospital's Adult HIV Clinic in Soweto, South Africa. Adherence was assessed using a 1-month, self-report questionnaire and was calculated as a ratio of doses taken to doses prescribed. The 66 patients studied had a mean age of 36.1 years, a median duration of ART use of 18 months, and an overall baseline median CD4(+) cell count of 200/mm(3) (IQR: 114-364). The adherence reported by these patients for the previous month was >95% for 58 patients (88%), 90-95% for 6 (9%) and, <90% for 2 (3%). The main reasons given for missing doses were being away from home (30%), difficulty with the dosing schedules (23%), and running out of pills (12%). Adherence decreased considerably with fear of being stigmatized by the sexual partner (OR = 0.13 95%, CI 0.02-0.70). Plasma HIV RNA levels were <400 copies/ml in the majority of patients (73% of those with adherence >95% and 88% of patients with less than or equal to95% adherence) and the overall median CD4(+) cell count rose to 324/mm(3) (IQR: 193-510). High adherence and viral suppression are achievable for a significant proportion of HIV-infected patients taking ART in a resource-limited area such as Soweto, South Africa. Strategies to maximize adherence in this setting should emphasize ready access to affordable and simple ART regimens, as well as HIV education programs to help increase awareness and decrease disease stigmatization.
引用
收藏
页码:1053 / 1056
页数:4
相关论文
共 10 条
[1]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[2]   Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments [J].
Chesney, MA ;
Ickovics, JR ;
Chambers, DB ;
Gifford, AL ;
Neidig, J ;
Zwickl, B ;
Wu, AW .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03) :255-266
[3]   Preventing antiretroviral anarchy in sub-Saharan Africa [J].
Harries, AD ;
Nyangulu, DS ;
Hargreaves, NJ ;
Kaluwa, O ;
Salaniponi, FM .
LANCET, 2001, 358 (9279) :410-414
[4]   The Senegalese government's highly active antiretroviral therapy initiative:: an 18-month follow-up study [J].
Laurent, C ;
Diakhaté, N ;
Gueye, NFN ;
Touré, MA ;
Sow, PS ;
Faye, MA ;
Gueye, M ;
Lanièce, I ;
Kane, CT ;
Liégeois, F ;
Vergne, L ;
Mboup, S ;
Badiane, S ;
Ndoye, I ;
Delaporte, E .
AIDS, 2002, 16 (10) :1363-1370
[5]   Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: A 5-year cohort study [J].
Lucas, GM ;
Chaisson, RE ;
Moore, RD .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (03) :321-328
[6]   Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions [J].
Lucas, GM ;
Chaisson, RE ;
Moore, RD .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (02) :81-+
[7]   Adherence is not a barrier to successful antiretroviral therapy in South Africa [J].
Orrell, C ;
Bangsberg, DR ;
Badri, M ;
Wood, R .
AIDS, 2003, 17 (09) :1369-1375
[8]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860
[9]   Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [J].
Paterson, DL ;
Swindells, S ;
Mohr, J ;
Brester, M ;
Vergis, EN ;
Squier, C ;
Wagener, MM ;
Singh, N .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (01) :21-30
[10]   Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance [J].
Weidle, PJ ;
Malamba, S ;
Mwebaze, R ;
Sozi, C ;
Rukundo, G ;
Downing, R ;
Hanson, D ;
Ochola, D ;
Mugyenyi, P ;
Mermin, J ;
Samb, B ;
Lackritz, E .
LANCET, 2002, 360 (9326) :34-40